Hongguang Nie | Infectious Diseases | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Hongguang Nie
China Medical University

Hongguang Nie
Affiliation China Medical University
Country China
Scopus ID 7103200378
Documents 69
Citations 1143
h-index 17
Subject Area Infectious Diseases
Event Health Scientists Awards
ORCID 0000-0002-9973-6354

The Innovative Research Award recognizes researchers whose scholarly contributions demonstrate sustained impact within their scientific disciplines. Hongguang Nie of China Medical University has established a notable research profile in infectious diseases through peer-reviewed publications, citation influence, and interdisciplinary collaboration. His research activities have contributed to advancing knowledge related to infectious disease mechanisms, clinical outcomes, epidemiology, and healthcare improvement initiatives. The academic record represented through indexed publications and citation metrics reflects continuing engagement with scientific inquiry and evidence-based healthcare research.[1]

Abstract

Hongguang Nie is a researcher affiliated with China Medical University whose scholarly activities are focused primarily on infectious diseases and related biomedical investigations. His publication portfolio demonstrates engagement with epidemiology, disease mechanisms, clinical research, public health applications, and healthcare outcomes. With a documented record of 69 indexed publications, 1,143 citations, and an h-index of 17, his work has achieved measurable visibility within the scientific community. The breadth of his contributions reflects sustained participation in evidence-based research, interdisciplinary collaboration, and the dissemination of findings that support improved understanding of infectious disease challenges and healthcare advancement.[1]

Keywords

Infectious Diseases, Epidemiology, Clinical Research, Public Health, Disease Prevention, Healthcare Outcomes, Biomedical Science, Medical Research, Infection Control, Translational Medicine

Introduction

Research in infectious diseases remains essential for understanding pathogen transmission, disease progression, prevention strategies, and clinical interventions. Hongguang Nie has contributed to this field through scholarly publications that support evidence-based medical knowledge and healthcare improvement. His research activities align with contemporary priorities in disease control, epidemiology, and public health advancement.[2]

Research Profile

Hongguang Nie is affiliated with China Medical University and maintains an active research profile within infectious diseases. His scholarly record includes peer-reviewed publications indexed in international databases, demonstrating ongoing participation in biomedical research. Citation performance and publication productivity indicate sustained engagement with scientific investigation and collaborative academic endeavors.[1]

Research Contributions

The research contributions of Hongguang Nie encompass infectious disease studies, clinical investigations, healthcare outcome assessments, and epidemiological analyses. His publications have supported understanding of disease-related challenges and informed evidence-based approaches in medical science. Collaborative research efforts further demonstrate his commitment to advancing knowledge through multidisciplinary scientific inquiry.[3]

Publications

The publication record associated with Hongguang Nie includes articles published in recognized scientific journals addressing infectious diseases and related healthcare topics. These works contribute to the dissemination of research findings and facilitate scholarly dialogue. Indexed publications and associated citations reflect the visibility and relevance of his research outputs within the academic community.[1]

Research Impact

Research impact can be evaluated through publication influence, citation metrics, and scholarly engagement. With more than one thousand citations and a measurable h-index, Hongguang Nie’s work demonstrates recognition within relevant research communities. His studies contribute to the broader scientific understanding of infectious diseases and support ongoing developments in healthcare research.[1]

Award Suitability

Hongguang Nie’s scholarly achievements, publication record, citation performance, and research focus in infectious diseases align with the objectives of the Innovative Research Award. His demonstrated commitment to scientific investigation and knowledge dissemination supports consideration for recognition within the Health Scientists Awards framework and related academic evaluation processes.[1]

Conclusion

Hongguang Nie has developed a credible academic profile through sustained contributions to infectious disease research. His publication output, citation record, and engagement in scientific collaboration illustrate continued involvement in advancing medical knowledge. These accomplishments support recognition within academic award programs dedicated to research excellence and healthcare innovation.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Hongguang Nie, Author ID 7103200378. Scopus. https://www.scopus.com/authid/detail.uri?authorId=7103200378
  2. Xin, S., Ding, Y., Yu, T., et al. (2025). Mesenchymal Stem Cell-Secreted KGF Ameliorates Acute Lung Injury via the Gab1/ERK/NF-κB Signaling Axis. https://pubmed.ncbi.nlm.nih.gov/40640718/
  3. Li, X., Fu, Y., Yu, T., Song, R., Nie, H., & Ding, Y. (2025). Anti-Oxidant, Anti-Inflammatory and Antiviral Properties of Luteolin Against SARS-CoV-2: Based on Network Pharmacology.     https://pubmed.ncbi.nlm.nih.gov/41011200

Kenjiro Nagai | Infectious Diseases | Research Excellence Award

Published on by Health Scientists

Research Excellence Award

Kenjiro Nagai
Ebina Centro Clinic, Japan

Kenjiro Nagai
Affiliation Ebina Centro Clinic
Country Japan
Scopus ID 56915217000
Documents 20
Citations 585
h-index 12
Subject Area Infectious Diseases
Event Health Scientists Awards
ORCID 0000-0002-7726-7403

Kenjiro Nagai is a researcher affiliated with Ebina Centro Clinic whose scholarly work has contributed to the field of infectious diseases. His publication record, citation performance, and documented research activities demonstrate sustained engagement in clinical and scientific investigations relevant to disease prevention, diagnosis, treatment, and healthcare outcomes. The following article provides a structured overview of his research profile and potential suitability for recognition through the Health Scientists Awards.[1]

Abstract

Kenjiro Nagai has established a research profile centered on infectious diseases and clinically relevant healthcare investigations. His scholarly contributions encompass disease surveillance, patient management strategies, diagnostic evaluation, and evidence-based medical practice. Through a portfolio of peer-reviewed publications and measurable citation influence, his work has supported scientific understanding and practical healthcare applications. The documented research output reflects continuous engagement with contemporary challenges in infectious disease medicine. Bibliometric indicators, including citation performance and h-index, suggest sustained academic visibility. These accomplishments position his research activities as relevant to professional recognition within international scientific and healthcare award frameworks.[1][2]

Keywords

  • Infectious Diseases
  • Clinical Research
  • Disease Prevention
  • Epidemiology
  • Medical Science
  • Patient Care
  • Public Health
  • Health Research

Introduction

The field of infectious diseases remains essential for improving global health outcomes and strengthening healthcare systems. Researchers working within this discipline contribute to understanding disease transmission, treatment approaches, and preventive strategies. Kenjiro Nagai’s scholarly activities align with these objectives through clinically focused investigations and scientific dissemination.[1]

Research Profile

Affiliated with Ebina Centro Clinic in Japan, Kenjiro Nagai has developed a publication record comprising twenty indexed documents. His citation count and h-index indicate continuing academic engagement and recognition within relevant scientific communities focused on infectious diseases and healthcare research.[1]

Research Contributions

His contributions support the advancement of infectious disease knowledge through clinical observations, evidence generation, and publication of findings relevant to patient care. Such efforts contribute to broader scientific understanding and may assist healthcare professionals in informed clinical decision-making processes.[2]

Publications

The documented publication portfolio includes peer-reviewed research articles associated with infectious disease investigations. These works have generated measurable scholarly attention through citations and demonstrate participation in scientific communication, knowledge dissemination, and ongoing engagement with healthcare research topics.[1]

Research Impact

Bibliometric indicators suggest that Kenjiro Nagai’s research has achieved visibility within academic literature. Citation accumulation reflects scholarly use of published findings, while the h-index demonstrates a consistent level of influence across multiple research outputs within the infectious diseases domain.[1]

Award Suitability

Based on available research metrics, publication activity, and subject specialization, Kenjiro Nagai demonstrates characteristics commonly evaluated in scientific recognition programs. His documented contributions to infectious disease research align with the objectives of awards honoring healthcare innovation and scientific advancement.[3]

Conclusion

Kenjiro Nagai’s academic record reflects meaningful engagement in infectious disease research and clinical scholarship. His publication achievements, citation impact, and professional contributions collectively indicate a sustained commitment to advancing medical knowledge and supporting evidence-based healthcare practices.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Kenjiro Nagai, Author ID 56915217000. Scopus.https://www.scopus.com/authid/detail.uri?authorId=56915217000

  2. Nagai, K., Nagai, S., et al. (2025). Report on Successful Treatment of Refractory MAC Lung Disease in Two Elderly Patients with Inhaled Liposomal Amikacin (ALIS) at Half the Standard Dose.

    https://doi.org/10.1016/S1473-3099(20)30154-9

  3. Health Scientists Awards. Award evaluation framework and recognition objectives.https://healthscientists.org/

Sulymon Saka | Infectious Diseases | Best Researcher Award

Published on by Health Scientists

Dr. Sulymon Saka | Infectious Diseases | Best Researcher Award

Resident doctor | Irrua Specialist Teaching Hospital | Nigeria

Dr. Sulýmon Ayobami Saka is an emerging Nigerian physician-scientist whose research bridges clinical medicine, audiology, infectious disease epidemiology, and the integration of artificial intelligence in healthcare. Trained at Ambrose Alli University with first-class honours equivalent in Medicine and Surgery, he has established a distinguished record of multidisciplinary research that spans global health, otolaryngology, and data-driven clinical innovation. His academic contributions include multiple peer-reviewed publications in high-impact journals such as BMC Infectious Diseases, BMC Public Health, and the Journal of Otolaryngology – Head & Neck Surgery, reflecting his commitment to evidence-based advancement in medicine. Dr. Saka’s research experience extends across several international collaborations, including the Bernhard Nocht Institute for Tropical Medicine in Germany and Sleep & Cradle® Solutions in the United States, where he contributes to studies on Lassa fever vaccine development, digital maternal and paediatric health, and long-term sequelae of infectious diseases. His scientific works emphasize the intersection of technology and clinical care—exploring how artificial intelligence, digital health platforms, and precision diagnostics can improve health outcomes in low- and middle-income settings. Recognized with multiple awards, including the ECOWAS Lassa Fever International Conference Scholarship and the Newcastle University Vice-Chancellor’s International Scholarship, Dr. Saka exemplifies a new generation of African medical researchers advancing global scientific dialogue. Through his leadership in research and mentorship, he continues to contribute to projects that not only enhance disease surveillance and clinical epidemiology but also foster equitable access to healthcare innovations. His work underscores a vision for a future where interdisciplinary science, cross-border collaboration, and artificial intelligence converge to transform patient care and strengthen health systems across the developing world. He has 9 citations from 9 documents with an h-index of 2.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Sibomana, O., Saka, S. A., Grace Uwizeyimana, M., Mwangi Kihunyu, A., Obianke, A., Oluwo Damilare, S., Bueh, L. T., Agbelemoge, B. O. G., & Omoefe Oveh, R. (2025). Artificial Intelligence–Assisted Endoscopy in Diagnosis of Gastrointestinal Tumors: A Review of Systematic Reviews and Meta-Analyses. Gastro Hep Advances.

2. Blackie, F. F., Saka, S. A., Ikhifa, C. E., Okechukwu, E. J., & Agbonifo, M. (2025). Aural Myiasis in a Retroviral-Positive Nigerian Child: A Rare Case of Extensive Ear Infestation. Research Square.

3. Emekolom, O. N., Oladipupo, E. O., Saka, S. A., Ojo, D. O., Edhugo, S. E., Olayinka, A. J., & Aremu-Cole, A. H. (2025). Compliance with Universal Standard Precautions and Perceived Influencing Factors among Nurses in a Tertiary Institution in Edo State, Nigeria. Asian Journal of Research in Nursing and Health.

4. Akhigbe, M. E., Saka, S. A., Ighodaro, O., Ghouse, M. A., Emekolom, O. N., & Okoro, O. V. (2025). Doctors’ Knowledge, Attitudes and Prescription Practices on Antibiotic Use: A Study in a Suburban Tertiary Hospital in Nigeria. BMC Health Services Research.

5. Saka, S. A., Ojo, D. O., Mezu, N. M., Uzuegbu, C. O., Ighodaro, O., Illoh, O. O., Emekolom, O. N., Akpa, O. A., Obiora, E. A., & Muogbo, A. P. (2025). Knowledge, Perception and Preventive Practices of Lassa Fever Among Mothers of Under-Five Children in an Endemic Community in Edo State, Nigeria. Research Square.

Mohammad Mehdi Akbarin | Virology | Best Researcher Award

Published on by Health Scientists

Dr. Mohammad Mehdi Akbarin | Virology | Best Researcher Award 

Postdoctoral Fellow | UNAM | Mexico

Dr. Mohammad Mehdi Akbarin is a distinguished Iranian immunologist and molecular virologist whose academic and research pursuits bridge medical immunology, viral oncology, and immunogenetics. Currently serving as a Postdoctoral Fellow in Virology at the Facultad de Estudios Superiores Cuautitlán, Universidad Nacional Autónoma de México (FESC–UNAM), his work focuses on understanding genetic variations that influence susceptibility and resistance to Bovine Leukemia Virus infection in cattle, contributing to translational advancements in comparative immunovirology. He earned his Ph.D. and M.Sc. in Medical Immunology from Mashhad University of Medical Sciences, where his pioneering research on HTLV-1 molecular pathogenesis, recombinant antigen development, and immunotherapeutic target design laid a foundation for novel diagnostic and therapeutic strategies against viral-associated malignancies such as Adult T-cell Leukemia/Lymphoma. Dr. Akbarin has authored and co-authored numerous peer-reviewed publications in high-impact international journals, covering areas such as cell signaling, host-virus interactions, and immune regulatory mechanisms, while also contributing to scientific books on human T-lymphotropic viruses and related diseases. His interdisciplinary collaborations span institutions across Iran, South Korea, and Mexico, underscoring his global engagement in biomedical research. Beyond his scholarly output, he has played instrumental roles in organizing international scientific congresses and mentoring medical and laboratory science students in immunology, bacteriology, and molecular diagnostics. His contributions to immunogenetics and translational virology have advanced the understanding of viral immune modulation and disease progression, reinforcing the link between molecular research and public health applications. Dr. Akbarin’s scientific vision centers on developing integrative molecular approaches for infectious disease control, cancer immunotherapy, and system biology-driven therapeutic innovation, embodying a commitment to advancing medical science and improving global health outcomes through precision immunology. He has 120 citations from 19 documents with an h-index of 7.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Tarokhian, H., Rahimi, H., Mosavat, A., Shirdel, A., Rafatpanah, H., Akbarin, M. M., et al. (2018). HTLV-1–host interactions on the development of adult T cell leukemia/lymphoma: Virus and host gene expressions.

2. Akbarin, M. M., Rahimi, H., HassanNia, T., Razavi, G. S., Sabet, F., & Shirdel, A. (2013). Comparison of HTLV-I proviral load in adult T cell leukemia/lymphoma (ATL), HTLV-I-associated myelopathy (HAM-TSP) and healthy carriers.

3. Ramezani, S., Shirdel, A., Rafatpanah, H., Akbarin, M. M., Tarokhian, H., et al. (2017). Assessment of HTLV-1 proviral load, LAT, BIM, c-FOS and RAD51 gene expression in adult T cell leukemia/lymphoma. Medical Microbiology and Immunology

4. Akbarin, M. M., Shirdel, A., Bari, A., Mohaddes, S. T., Rafatpanah, H., Karimani, E. G., et al. (2017). Evaluation of the role of TAX, HBZ, and HTLV-1 proviral load on the survival of ATLL patients. Blood Research.

5. Jafarian, M., Mozhgani, S. H., Patrad, E., Vaziri, H., Rezaee, S. A., Akbarin, M. M., et al. (2017). Evaluation of INOS, ICAM-1, and VCAM-1 gene expression: A study of adult T cell leukemia malignancy associated.

Jack Ogony | Infectious Diseases | Outstanding Scientist Award

Published on by Health Scientists

Dr. Jack Ogony | Infectious Diseases | Outstanding Scientist Award

Research Associate | Jaramogi Oginga Odinga University | Kenya

Dr. Jack Ogony is a distinguished Research Associate at the Institute for Health Research, Epidemiological Surveillance and Trainings (IRESSEF), with over 13 years of extensive experience in public health research across Sub-Saharan Africa. He is currently completing his PhD in Epidemiology and Biostatistics at Jomo Kenyatta University of Agriculture and Technology, having previously earned a Master’s in Epidemiology from the same institution, a Postgraduate Certificate in Monitoring and Evaluation from the Kenya Institute of Management, and a BSc in Medical Laboratory Science from Masinde Muliro University of Science and Technology. Dr. Ogony’s research primarily focuses on epidemiology, infectious diseases, climate change impacts on health systems, and vaccine and drug trial studies. He has contributed significantly to understanding the burden of Plasmodium falciparum and Dengue virus infections among under five in Western Kenya and the wider implications of climate change on African healthcare infrastructure. His work has been published in high-impact journals including Frontiers in Public Health, PLOS Global Public Health, and the East African Medical Journal, others, reflecting both the depth and breadth of his contributions. He has also served as Principal Investigator on multiple USAID-funded  under the Climate Adaptation Research Program (CARP). Recognized for his leadership and expertise, Dr. Ogony is a member of several professional organizations, including the American Society of Tropical Medicine and Hygiene and the African Society for Laboratory Medicine. He has earned awards for scientific excellence and serves as a peer reviewer for multiple journals, contributing to the advancement of global health research and capacity building in and infectious disease control across Africa. He has 28 citations from 5 documents with an h-index of 2.

Profile: Scopus | ORCID

Publications

1. Ogony, J., Menya, D., Mangeni, J. N., Ayodo, G., & Karanja, S. M. (2025). Public health facility vulnerabilities, preparedness and health outcomes for P. falciparum and Dengue virus infected children under 5 years with acute febrile illnesses in Western Kenya. Frontiers in Public Health, 13, 1526558.

2. Ogony, J., Mangeni, J., Ayodo, G., Amulen, E., Scopas, F., Juma, T., … & Hannah, C. (2025). The stifling burden of climate change on African public healthcare systems. Frontiers in Public Health, 13, 1559737.

3. Ogony, J., Karanja, S., Menya, D., Mangeni, J., & Ayodo, G. (2024). Prevalence and risk factors of Plasmodium falciparum and Dengue virus infections among children below 5 years with acute febrile illnesses in Kisumu and Busia Counties. East African Medical Journal, 101(12).

4. Owusu Agyare, B., Eder, P., Shenai, S., Chendi, B. H., Carlson, C., Iradukunda, A., Mukoka, M., Ogony, J., Manigart, O., O., O., Ogbaini-Emovon, E., & Seida, A. A. (2024). Potential implications of the climate crisis on diagnostics. PLOS Global Public Health, 4(3), e0002935.

5. Ogony, J., Obiero, B., Tukhuwa, B., Gondwe, C., Kampeta, E., Orner, C., & Tiruneh, T. (2021). Research knowledge translation activities in Africa: An outlook of the opportunities and obstacles. International Journal of Scientific Advances, 2(5), 8.